Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.
Hussein, T., Gomaa, A., Hassan, E., Abd elhamid, F. (2024). Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.. EKB Journal Management System, 13(1), 19-26. doi: 10.21608/fumj.2024.237094.1263
Tasneem Gaber Hussein; Ahmed Ali Gomaa; Essam Ali Hassan; Fatma Mohamed Abd elhamid. "Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.". EKB Journal Management System, 13, 1, 2024, 19-26. doi: 10.21608/fumj.2024.237094.1263
Hussein, T., Gomaa, A., Hassan, E., Abd elhamid, F. (2024). 'Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.', EKB Journal Management System, 13(1), pp. 19-26. doi: 10.21608/fumj.2024.237094.1263
Hussein, T., Gomaa, A., Hassan, E., Abd elhamid, F. Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.. EKB Journal Management System, 2024; 13(1): 19-26. doi: 10.21608/fumj.2024.237094.1263

Evaluation of Fibrosis Regression Using FIB-5 Score in HCV and HBV Positive Patients after Treatment and Virus Suppression Respectively.

Fayoum University Medical Journal
Volume 13, Issue 1, January 2024, Page 19-26  XML PDF (279.88 K)
Document Type: Full Length research Papers
DOI: 10.21608/fumj.2024.237094.1263
View on SCiNiTO View on SCiNiTO
Authors
Tasneem Gaber Hussein email 1; Ahmed Ali Gomaa2; Essam Ali Hassan2; Fatma Mohamed Abd elhamid3
1Tropical medicine department faculty of medicine fayoum University elfayoum
2faculty of medicine fayoum university
3Tropical medicine department faculty of medicine fayoum University
Abstract
Background: Chronic liver disease (CLD) is a major cause of morbidity and mortality worldwide. Assessment of liver fibrosis (LF) via the utilization of noninvasive tests (NITs) has been emerging nowadays. These NITs as FIB-4 and FIB-5 have adequate predictive positive value (PPV) for diagnosis of nil or minimal fibrosis up to advanced fibrosis.
Aim of the work: Detect fibrosis regression after HCV treatment and HBV suppression using FIB-5 score and evaluation of the accuracy of FIB-5 score as a validated NIT of fibrosis compared to FIB-4.
Patients and methods: This is a prospective study on 100 patients with chronic hepatitis, 50 HCV patients who received direct acting anti-viral drugs (DAAs) about 5 years ago and achieved sustained virological response (SVR) and 50 HBV patients with undetected viremia and still on treatment according to the national program for treatment of HCV and Egyptian guidelines for HBV treatment respectively.
Results: Sensitivity and specificity test for FIB-5 level post-treatment in diagnosis of fibrosis regression in HCV patients were (88.2%, and 63.6% respectively) at cutoff value -14.695. Sensitivity and specificity test for FIB-5 level post-treatment in diagnosis of fibrosis regression in HBV patients were (57.1%, and 94.4% respectively) at cutoff value -8.68.
Conclusion: FIB-5 is both specific and sensitive test to assess fibrosis regression in chronic hepatitis patients after and on treatment.
Keywords: chronic liver disease; liver fibrosis; cirrhosis; FIB-4; FIB-5
Keywords
chronic liver disease; liver fibrosis; cirrhosis; FIB-4; FIB-5
Statistics
Article View: 47
PDF Download: 77